By Vincent H Karam et al, Hôpital Paul Brousse, Villejuif, France. Liver transplantation is associated with consistent improvements in quality of life in the first three years after… read more.
by Bruce Sylvester: Fenofibrate treatment reduces cardiovascular disease risks in persons with type-2 diabetes, especially women, researchers reported on August 18 in Diabetologia.
Feature Symposium. Stephen Strom, Karolinska Institutet, Stockholm, Sweden. Luc van der Laan, Erasmus Medical Center, Rotterdam, the Netherlands. Alberto Sanchez-Fueyo, King’s College Hospital, London, UK. David Hay, University… read more.
by Professor John O’Grady, Kings College Hospital, London – Liver transplantation is highly successful from the technical perspective, returning the majority of patients to a level of health… read more.
by Bruce Sylvester – Type 2 diabetes patients consuming a high-salt diet double their risk of developing cardiovascular disease, researchers reported on July 22, 2014 in the Journal… read more.
Sustained release treatment option could soon be available for diabetic patients in 28 countries of the European Union.
by Gary Finnegan – The EMA’s influential Committee for Medicinal Products for Human Use (CHMP) approved six new medicines at its June meeting, including a breakthrough hepatitis C… read more.
Adding canola oil to the diet improved glycemic control and reduced cardiovascular risk in type 2 diabetes in one study, while an overall healthier diet reduced risk of… read more.
Despite some concerns to the contrary, the use of insulin glargine (Lantus) is not associated with an increased risk of any cancer in people with diabetes or prediabetes,… read more.
A bihormonal “artificial pancreas” improved glycemic control and led to less hypoglycemia in type 1 diabetes patients, researchers reported here.
by Christine Clark – Insulin ranks among the top 10 ‘high-alert’ or high-risk medicines worldwide. (ref NPSA/2011/PSA003) It is also been an important cause of hospital admissions, mainly… read more.
National guidelines for lipids and blood pressure are likely to be a focus of attention at this year’s meeting of the American Diabetes Association.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
